Healio

VIDEO: Early drying of intraretinal fluid leads to better vision, anatomic outcomes in DME

Please provide your email address to receive an email when new articles are posted on . SEATTLE — In this Healio Video Perspective from the ARVO meeting, Dolly Shuo-Teh Chang, MD, of Genentech ...
Healio

VIDEO: Early intraretinal fluid reduction predictive of better outcomes in DME treatment

Please provide your email address to receive an email when new articles are posted on . BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Jennifer I. Lim, MD, speaks ...
Medscape

Does Residual Fluid Matter in Wet AMD?

Most retina specialists use a treat-and-extend approach for wet age-related macular degeneration (AMD), whereby anti–vascular endothelial growth factor (VEGF) injections are performed until the retina ...
Seeking Alpha

Adverum Biotechnologies Presents Anatomical Improvements in Intraretinal and Subretinal Fluid After a Single IVT Injection of Ixo-vec (ADVM-022) in the OPTIC Study in Wet AMD

- New data highlight that a single intravitreal injection of Ixo-vec can lead to stable and persistent aflibercept expression through three years resulting in fluid control supporting favorable vision ...
The American Journal of Managed Care

Short-Term Improvements Seen in Patients With nAMD Switching to Faricimab

Faricimab demonstrated short-term improvements in visual and anatomical outcomes for nAMD patients switching from other anti-VEGF therapies. The study showed reductions in central macular thickness, ...
Morningstar

Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal ...

Meaningful vision gains are rapidly achieved as early as week 4 and showed continued improvement in best corrected visual acuity (BCVA) through week 20, with more than half of patients achieving ...
Medscape

Real-World Results Show Sustainability, Safety of Faricimab

BARCELONA, Spain — Early findings from a real-world study of the dual-action antibody faricimab have shown sustained improvement in visual acuity and key biomarkers of retinal anatomy, with no new ...